Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy. 2021

Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Laparoscopic sleeve gastrectomy (LSG) significantly increases high-density lipoprotein cholesterol (HDL-C) and lipoprotein lipase (LPL) in pre-heparin serum (pre-heparin LPL levels). LPL is a regulator of serum triglyceride (TG) and HDL-C production; this may be the mechanism for HDL-C increase after LSG. This study aimed to elucidate the mechanism of increase in HDL-C levels by examining the relationship between changes in serum HDL-C levels and LPL after LSG. We retrospectively reviewed 104 obese patients, who underwent LSG and were followed up for 12 months. We analyzed the relationship between changes in serum HDL-C levels and various clinical parameters after LSG. A significant decrease was observed in the patients' BMI and serum TG levels after LSG. Conversely, HDL-C levels and pre-heparin LPL levels were significantly increased after LSG. Simple linear regression showed that changes in HDL-C levels were significantly correlated with total weight loss percentage, change in TG levels, abdominal fat areas, and pre-heparin LPL levels. Additionally, the multiple regression model revealed that a decrease in TG levels and an increase in pre-heparin LPL levels were correlated with increased HDL-C levels after LSG. These results show that a decrease in TG levels and an increase in LPL are mechanisms for increased HDL-C levels after LSG.

UI MeSH Term Description Entries
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D005743 Gastrectomy Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed) Gastrectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
September 2020, Annals of clinical biochemistry,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
October 2021, Biomarkers in medicine,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
April 1993, Annals of internal medicine,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
August 2023, Metabolic syndrome and related disorders,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
November 1987, Preventive medicine,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
January 2000, Neurobiology of aging,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
September 2006, Metabolism: clinical and experimental,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
September 1997, Metabolism: clinical and experimental,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
January 2005, Vascular health and risk management,
Masahiro Ohira, and Yasuhiro Watanabe, and Takashi Yamaguchi, and Hiroki Onda, and Shuhei Yamaoka, and Kazuki Abe, and Shoko Nakamura, and Sho Tanaka, and Naoyuki Kawagoe, and Taiki Nabekura, and Takashi Oshiro, and Daiji Nagayama, and Ichiro Tatsuno, and Atsuhito Saiki
December 2008, Schizophrenia research,
Copied contents to your clipboard!